Loading...
Thumbnail Image
Publication

Superior Therapeutic Potential of Young Bone Marrow Mesenchymal Stem Cells by Direct Intramyocardial Delivery in Aged Recipients with Acute Myocardial Infarction: In Vitro and In Vivo Investigation

Nayan, Madhur
Paul, Arghya
Chen, Guangyong
Chiu, Ray C. J.
Prakash, Satya
Shum-Tim, Dominique
Citations
Altmetric:
Abstract
Bone-marrow-derived mesenchymal stem cells (MSCs) have been studied for treatment of myocardial infarction (MI). Since MSCs from older donors show quantitative and qualitative senescent changes, we hypothesized that a better outcome may be achieved if aged recipients are given MSCs obtained from young donors, rather than using their own autologous MSCs. Methods. In vitro studies compared properties of young and old MSCs. Aged rats randomized into 3 groups underwent coronary artery ligations and were then injected with either old (O) or young (Y) MSCs, or ligation alone. Echocardiography evaluated ejection fractions (EF). At 16 weeks, scar deposition was analyzed. Results. Old MSCs exhibited decreased cell viability, proliferation, and differentiation potentials. EF significantly improved early in both cell therapy groups (P < .05). However, at later stages of the study, group Y showed significantly better function which correlated with decreased scar deposition. Conclusions. The significant difference between young and old cells indicates the possible advantage for allotransplanting MSCs from young donors to elderly patients with MI.
Description
Date
2011-05-27
Journal Title
Journal ISSN
Volume Title
Publisher
SAGE Publications
Research Projects
Organizational Units
Journal Issue
Keywords
Citation
Nayan, Madhur, Arghya Paul, Guangyong Chen, Day C. J. Chiu, Satya Prakash, and Dominique Shum-Tim. "Superior Therapeutic Potential of Young BoneMarrow Mesenchymal StemCells by Direct Intramyocardial Delivery in Aged Recipients with AcuteMyocardial Infarction: In Vitro and In Vivo Investigation." Journal of Tissue Engineering 2011 (2011)
Embedded videos